A detailed history of Corient Capital Partners, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Corient Capital Partners, LLC holds 21,574 shares of TAK stock, worth $298,799. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,574
Previous 21,574 -0.0%
Holding current value
$298,799
Previous $303,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$13.12 - $15.03 $8,226 - $9,423
-627 Reduced 2.82%
21,574 $303,000
Q1 2022

May 16, 2022

BUY
$13.54 - $15.35 $35,190 - $39,894
2,599 Added 13.26%
22,201 $318,000
Q4 2021

Feb 11, 2022

BUY
$13.17 - $16.4 $25,062 - $31,209
1,903 Added 10.75%
19,602 $267,000
Q3 2021

Nov 16, 2021

BUY
$16.3 - $17.26 $288,493 - $305,484
17,699 New
17,699 $290,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.